Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.
Quantification of intrahepatic covalently closed circular DNA (cccDNA) is a key for evaluating an elimination of hepatitis B virus (HBV) in infected patients. However, quantifying cccDNA requires invasive methods such as a liver biopsy, which makes it impractical to access the dynamics of cccDNA in...
Saved in:
| Main Authors: | Kwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, Hyeongki Park, Sanae Hayashi, Senko Tsukuda, Takeshi Matsui, Masanori Atsukawa, Kentaro Matsuura, Natthaya Chuaypen, Pisit Tangkijvanich, Lena Allweiss, Takara Nishiyama, Naotoshi Nakamura, Yasuhisa Fujita, Eiryo Kawakami, Shinji Nakaoka, Masamichi Muramatsu, Kazuyuki Aihara, Takaji Wakita, Alan S Perelson, Maura Dandri, Koichi Watashi, Shingo Iwami, Yasuhito Tanaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://doi.org/10.1371/journal.pcbi.1012615 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
by: Kouichi Kitamura, et al.
Published: (2018-06-01) -
Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers.
by: Kosaku Kitagawa, et al.
Published: (2024-03-01) -
Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01) -
Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products
by: Liyuan Hao, et al.
Published: (2025-06-01) -
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
by: Patricia Gita Naully, et al.
Published: (2025-01-01)